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Abstract
Background: A considerable proportion of contemporary youth have a high risk of obesity-related disorders such
as cardiovascular disease, metabolic syndrome, or non-alcoholic fatty liver disease (NAFLD). Although there is consistent
evidence for the positive effects of physical activity on several health aspects, most adolescents in Colombia are
sedentary. It is, therefore, important to implement strategies that generate changes in lifestyle. The HEPAFIT study
aims to examine whether a 6-month exercise program has benefits for hepatic fat content and cardiovascular health
outcomes among overweight/obese adolescents from Bogotá, Colombia.
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Methods/design: Altogether, 100 hundred overweight/obese, sedentary adolescents (aged 11–17 years) attending two
public schools in Bogotá, Colombia, will be included in a parallel-group randomized controlled trial. Adolescents will be
randomly assigned to an intervention group following one of four curricula: (1) the standard physical education
curriculum (60 min per week of physical activity, n = 25) at low-to-moderate intensity; (2) a high-intensity physical
education curriculum (HIPE, n = 25), consisting of endurance and resistance games and non-competitive activities,
such as running, gymkhanas, lifting, pushing, wrestling, or hauling, for 60-min sessions, three times per week, with
an energy expenditure goal of 300 to 500 kcal/session at 75–85% maximum heart rate (HRmax); (3) a low-to-moderate
intensity physical education curriculum (LIPE, n = 25) consisting of endurance and resistance games and non-competitive
activities (e.g., chasing, sprinting, dribbling, or hopping) for 60-min sessions, three times per week with an energy
expenditure goal of 300 kcal/session at 55–75% HRmax; and (4) a combined HIPE and LIPE curriculum (n = 25).
The HIPE, LIPE, and combined interventions were performed in addition to the standard physical education curriculum.
The primary outcome for effectiveness is liver fat content, as measured by the controlled attenuation parameter 1
week after the end of the intervention program.
Discussion: The translational focus may be suitable for collecting new information in a school setting on the
possible effects of physical activity interventions to reduce liver fat content and to improve metabolic profiles
and the cardiometabolic health of overweight/obese adolescents. This may lead to the more efficient use of
school physical education resources.
Trial registration: ClinicalTrials.gov, NCT02753231. Registered on 21 April 2016.
Keywords: Exercise, Risk factor, Fatty liver, Metabolic syndrome, Overweight, Obesity
Background
Pediatric non-alcoholic fatty liver disease (NAFLD) is
considered the hepatic manifestation of metabolic syn-
drome and is the most common early driver of chronic
liver disease in the United States [1]. However, the true
prevalence of pediatric NAFLD is still not known for the
following reasons: (i) to date, only a few population
studies have been conducted in pediatric populations,
(ii) different screening or diagnostic methods were used,
and (iii) sex and ethnic differences were also reported
[2]. In obese child populations, the prevalence of
NAFLD ranges between 7.6% and 34.2% [3]. Moreover,
the prevalence of NAFLD has increased in parallel with
the prevalence of obesity, metabolic syndrome, and type
2 diabetes [2]. There is an association between obesity,
especially abdominal obesity, with visceral adipose tissue
and hepatic fat. Obesity induces metabolic disorders,
such as NAFLD, through diverse pathways that involve
adipocytokines, insulin and leptin resistance, overpro-
duction of free radicals, and inflammation of adipose
and liver tissue. If body fat is accumulated predomin-
ately in the upper body or abdominal cavity, the fat is
mainly visceral, which has a greater impact on liver fat
content and also positively correlates with the potential
for developing NAFLD [4, 5].
The metabolic complexity of NAFLD presents challenges
for a deeper understanding of the metabolic pathways that
contribute to the development of this pathology [6, 7]. In
the last few years, a growing number of studies have dem-
onstrated that non-traditional biomarkers (Additional file 1:
Table S1) that function as regulators of metabolic function
may be involved in the etiopathogenesis of NAFLD and
other metabolic disorders [8, 9]. Progress may be aided by a
comprehensive metabolic analysis of the condition before
and after the disease is established. Thus, several studies
have observed that oxidative stress, inflammation, and insu-
lin resistance are implicated in several aspects of glucose
homeostasis and lipid metabolism and are associated with
the pathogenesis and progress of NAFLD [10]. Moreover,
non-traditional biomarkers may be used to assess biological
adaptations to physiological changes or environmental
exposures, such as lifestyle intervention programs based
on increasing physical activity levels, improving dietary
habits, and promoting a healthy weight. Likewise, the
measurement of non-traditional and classical bio-
markers, such as hepatic metabolism and cardiovascular
biomarkers, presents an opportunity to evaluate biological
changes associated with lifestyle interventions to reduce
metabolic disorders associated with NAFLD progres-
sion, such as oxidative stress, inflammation, and insulin
resistance.
There is evidence that sedentary lifestyles and unhealthy
diets (especially those that are high in fats, free sugars, and
salt) are driving the obesity epidemic and its co-morbidities
in pediatric populations [11]. However, no medications or
surgical procedures have been approved for the treatment
of NAFLD. In turn, regular physical exercise has been
shown to promote positive adaptations among obese
children and adolescents [12]. Currently, there are no
dietetic or physical activity guidelines for the management
of NAFLD in children and youth. However, practice
guidelines from the American Association for the Study of
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Liver Diseases have recommended lifestyle interventions
to reduce body weight by 7–10% as the primary preven-
tion and management of NAFLD in adults [13]. A recent
meta-analysis in an obese pediatric population supports
the current recommendation for physical exercise, mainly
aerobic, as an effective intervention to counteract NAFLD
progression by targeting hepatic lipid composition, vis-
ceral adipose tissue, and subcutaneous adipose tissue
[14]. Still, the optimal exercise type (aerobic, resistance,
or combined exercise training) and intensity (moderate
or vigorous) to slow NAFLD progression in young pop-
ulations is unclear.
Previous systematic reviews and meta-analyses in obese
children and adolescents have shown that exercise reduces
cardiometabolic risk factors, such as visceral adiposity [14],
insulin resistance [12], inflammatory biomarkers [15], and
hepatic lipid composition [14]. In addition, a growing body
of evidence has demonstrated comparable or superior
improvements in cardiometabolic health outcomes using
low-volume, high-intensity interval training (HIIT) com-
pared with traditional moderate-intensity continuous train-
ing (MICT) in adults [16] and the young population [17].
In a clinical setting, HIIT is an effective way of performing
high-intensity exercise training and developing a high level
of cardiorespiratory fitness [16]. A recent meta-analysis
of 28 trials confirmed that both MICT and HIIT elicit
large improvements in peak VO2 of healthy, young to
middle-aged adults, with the effects being greater for
the less fit [16]. Moreover, few HIIT interventions in
children or adolescents have studied the effects on hepatic
adiposity parameters, so further research is required.
Recently, Medrano et al. [18] proposed that a multidiscip-
linary intervention program including education healthy
lifestyles, psychoeducation, and supervised exercise could
play a key role in reducing hepatic fat and cardiometabolic
risk in overweight children. In this context, four previous
studies in children and adolescents examined the effect of
supervised exercise without caloric restriction on hepatic
fat [19–22]. However, the majority of the studies do not
aim to identify non-traditional biomarkers as the surrogate
end point of NAFLD. Previous reports observed changes in
some circulating traditional biomarkers after liraglutide
therapy [23] or exercise in NAFLD adults [24]. In obese
youth, several P-selectins, endocan [25], insulin-like growth
factor 1 [26], and some proinflammatory cytokines [27]
have been proposed as biomarkers of endothelial dysfunc-
tion, dyslipidemia, inflammation, insulin resistance, and
NAFLD. As far as we are aware, there are no previous stud-
ies identifying the profile of non-traditional biomarkers in
adolescents at a high risk of NAFLD and the response to
an intervention with exercise.
Given that physical exercise increases insulin sensitivity,
increases oxidative metabolic activity, and reduces hepatic
fat and cardiometabolic risk in a young obese population,
the HEPAFIT study aims to examine whether a 6-month
exercise program has benefits for hepatic fat content and
inflammation as well as cardiovascular health outcomes
among adolescents from Bogotá, Colombia, who are over-
weight or obese.
Methods/design
Study design, setting, and participants
The HEPAFIT study is a single-blind parallel-group
randomized controlled trial (ClinicalTrials.gov ID
NCT02753231). All parents or guardians will provide in-
formed written consent and all the adolescents must give
assent before being enrolled in the study. The study re-
ceived ethical approval from the Medical Research Ethics
Committee of the University of Rosario (ID UR-21042016).
Random allocation to treatments will be performed at the
individual level.
The study will include 100 adolescents (50% females)
between 11 and 17 years of age attending to two public
schools in the urban area of Bogotá D.C., Colombia.
Inclusion criteria include primary overweight/obese
status, defined according to the International Obesity
Task Force [28], inactivity (no habitual participation in
exercise more than once a week in the previous 6
months), and having at least one parent or caregiver
willing to participate in the program sessions. Adoles-
cents eligible for the present study will be invited to a
pre-test, which will include a medical interview at the
Centre for Studies of Physical Activity Measurements
(in Spanish, CEMA), School of Medicine and Health
Sciences, University of Rosario, Bogotá, Colombia. Risks
will be minimized by identifying contraindications to the
testing and training protocols via a health history and a
thorough physical examination prior to the testing sessions.
The exclusion criteria include having a clinical diagnosis of
cardiovascular disease, having type 1 or type 2 diabetes
mellitus, being pregnant, using alcohol or drugs, and not
having lived in Bogotá for at least one school year. Adoles-
cents with other causes of liver disease in the pediatric
population that produce elevated liver enzyme levels will be
excluded. These will be identified by screening for hepato-
tropic viruses (hepatitis A, B, and C, cytomegalovirus, and
Epstein–Barr virus) and alpha-1 antitrypsin (A1AT) levels
as well as autoantibodies and immunoglobulin G to rule
out A1AT deficiency and autoimmune hepatitis, respect-
ively. This study aims to investigate the effects of these
interventions on risk factors for type 2 diabetes (i.e., its
focus is prevention) rather than looking at their effects on
treatment outcomes. Therefore, participants with estab-
lished type 2 diabetes are excluded.
Recruitment
Consecutive boys or girls with overweight/obesity will be
recruited from two public schools if they have received
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referrals from physician to either a primary- or
secondary-care general practitioner in the capital district of
Bogotá, Cundinamarca Department, in the Andean region.
After completion of the informed consent process, adoles-
cents who are interested in participating will be approached
with further information and undergo pre-participation
screening to determine contraindications to exercise using
a cardiovascular and musculoskeletal checklist (including
the patient’s medical history, disease history, and physical
fitness). A member of the research team will follow up with
a phone call to screen for eligibility and explain the main
requirements of the study.
Blinding and randomization methods
The randomization into the four study arms will be per-
formed by CEMA using a block randomization strategy
with a block size of four. Since growing adolescents have an
increasing body size and are undergoing developmental
changes, a control group is necessary to detect changes due
to training. After completing the baseline measurements,
eligible participants will be randomly assigned to either
the control or exercise training groups. The principal
investigator will coordinate the allocation sequence, and
randomization will be computer-generated. All participants
and study personnel (including investigators, trainers, and
statisticians) will be blinded to treatment allocation
throughout the trial protocol. Access to the allocation
code will be restricted to one study statistician who will not
perform the final study analyses. Randomization will be
conducted independently using sealed opaque envelopes.
These procedures are also detailed in the study operations
manual. Moreover, the importance of maintaining the
blinding and allocation concealment will be reinforced by
regularly scheduled conference calls at the sites and daily
meetings with the field investigators (Fig. 1).
Intervention
Participants will be randomly assigned to the following
groups.
Standard physical education curriculum
This is the control group (n = 25). These subjects will
not carry out any intervention different from the phys-
ical education class prescribed by the Colombian educa-
tion legislation (Legislation 115 of 1994, decree 1860 of
1994) [29], which is recognized as fundamental and is
consequently obligatory in all educational institutions in
the country. This session includes 60 min per week of
physical activity at low-to-moderate intensity. However,
during this period, education will be offered in lifestyles,
hygiene, and diet [30] at no cost to participants. Nutri-
tional counseling will be offered as well.
High-intensity physical education class
The high-intensity physical education group (HIPE group,
n = 25) will follow the standard physical education cur-
riculum plus the Physical Activity Intervention on the
Obesity of Schoolchildren (in Spanish, the MOVI-2 pro-
gram), which is based on a socio-ecological model and
targets the school, parents, teachers, and children, focus-
ing on increasing physical activity [31]. MOVI-2 includes
basic sports games, traditional games, and other outdoor
activities such as running, gymkhanas (which consist of
different types of competition with obstacles that make
the task difficult), lifting, pushing, wrestling, and hauling
(http://www.movidavida.org/), for 60-min sessions three
times per week for 6 months with an energy expenditure
goal of 300 to 500 kcal/session at 75–85% maximum heart
rate (HRmax).
For example, the prescribed energy expenditure during
exercise for month 1 is 300 kcal session− 1:
1. Conveyors game: Exercise energy
expenditure is 9.2 kcal min− 1 and exercise
duration is 100 kcal per session. Dividing by
9.2 kcal min− 1 gives 11 min per session.
2. Four corners game: Exercise energy expenditure is
10.8 kcal min− 1 and exercise duration is 100 kcal
per session. Dividing by 10.8 kcal min− 1 gives 9 min
per session.
3. Stealing handball game: Exercise energy expenditure is
9.4 kcal min− 1 and exercise duration = 100 kcal per
session. Dividing by 9.4 kcal min− 1 gives 10 min per
session.
All playground games will be preceded by a 5-min
warm up with endurance or resistance games (i.e., the
fastest, the clock, iceman, kangaroo race, etc.). The dur-
ation and intensity of all playground games sessions will
be verified by a downloadable heart rate (HR) monitor
(RS 400; Polar Electro Inc., Woodbury, NY) to achieve the
prescribed target HR. All activities will be implemented by
monitors with technical qualifications in physical activity
and sports, or by sport science graduates, specifically
engaged and adequately trained for the program. This
protocol is applicable for school-aged boys and girls, in-
dependent of the level of skill or their physical aptitude,
and is a health-oriented program aimed at balanced
physical and psychological development.
The MOVI program uses attractive alternative ma-
terials not often used in the subjects’ daily lives or in
the standard physical education classes. It is access-
ible, given that it occurs at the end of the classroom
activities in the school’s facilities or nearby. It is free
of charge and does not require the provision of any
specific equipment. In its first edition, the MOVI pro-
gram showed a moderate effect on reducing adiposity
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and improving the lipid profile but did not signifi-
cantly improve global cardiometabolic risk or lower
insulinemia [32]. In the second edition (MOVI-2), the
duration and intensity of the sessions were increased
and it was shown to enhance the development of
muscle strength further. Likewise, analyses showed re-
duced adiposity in both sexes, and an improvement
in the girls’ cardiovascular risk profile (low-density
lipoprotein cholesterol or LDL-C and insulin) was ob-
served [33]. The MOVI-2 program sessions that will
be used in this work are the following:
Frequency: 3 days per week excluding holidays and
vacation periods
Duration: 60 min, structured into 5 min of warm-up,
45 min dedicated to the main training curriculum, and
10 min dedicated to returning to a rest state
Protocol: Each of the sessions will work on activities
based on health-related physical fitness (cardiovascular
and muscle endurance and flexibility) at an intensity of
between 8.0 and 11.7 metabolic equivalents (MET). All
the games were performed previously by 32 schoolchildren
during sessions of the MOVI-2 program while indirect
calorimetry (through a portable gas analyzer), cardiac
frequency, and accelerometry were evaluated for each
game [34]. In addition, we have previously monitored the
implementation of all the games with overweight/obese
adolescents from Bogotá (unpublished observations).
Low-to-moderate intensity physical education class
The low-to-moderate intensity physical education group
(LIPE group, n = 25) will follow the standard physical edu-
cation curriculum. In addition, endurance and resistance
games from the MOVI-2 program will be used with a goal
to achieve an expenditure of 1500 kcal/week through
60-min sessions, three times per week for 6 months for
300 to 500 kcal energy expenditure per session at 55–75%
HRmax:
Frequency: Three times weekly, excluding holidays and
vacation periods
Duration: 60 min, structured into 5 min of warm-up,
45 min dedicated to the main training curriculum, and
10 min dedicated to returning to a rest state
Protocol: Each of the sessions will work on activities
based on health-related physical fitness (cardiovascular
and muscle endurance and flexibility) at an intensity of
between 4.0 and 7.0 MET.
Plus group
The combined group (n = 25) performed the 30-min aer-
obic training program plus the 30-min resistance training,
Fig. 1 CONSORT guidelines flow diagram for enrolment and randomization HEPAFIT Study
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that involve training program used in both HIPE and
LIPE. Each session is developed as described above. Add-
itionally, the standard physical education curriculum was
followed. The sum of both interventions should not ex-
ceed 1500 kcal/week of energy expenditure. All the study
participants in this group will receive a hygiene and diet-
ary management plan that includes educational and nutri-
tional support throughout the study.
After 3 months, the intensity will increase and a differ-
ent exercise sequence will be used until 6 months of inter-
vention have taken place. The exercise duration will be
adjusted to achieve the target average caloric expenditure
of 1500 kcal/week. Compliance to the exercise protocol,
an essential element of an efficacy study, will be defined as
successfully completing >90% of scheduled exercise ses-
sions, maintaining the target exercise HR ± 4 beats min− 1
for the prescribed duration of the playground games ses-
sion. The games proposed for this group are presented in
Table 1. It should be noted that diverse variations on the
games will be carried out to avoid monotony.
Training intensity and energy expenditure during training
Training intensity will be assessed using the mean HR
measured in the HIPE, LIPE or combined groups. The
exercise training program will be 100% supervised. At-
tendance at supervised sessions includes compliance with
target HR and energy expenditure and will be monitored
and recorded by research staff. Energy expenditure will be
estimated during exercise via indirect calorimetry using a
Cosmed K-5b2 portable metabolic system (Rome, Italy),
assuming a non-protein respiratory exchange ratio [35].
This procedure will be assessed for 30% of participants to
Table 1 Example of playground games ranked by oxygen consumption and energy expenditure with accelerometer counts and
heart rate data also displayed for the HEPAFIT study













17.9(5.8) 5.2 (0.8) 868 (312) 150 (10)
The clock 18.8 (8.8) 5.5 (2.6) 1772 (380) 147 (10)






20.3 (5.6) 5.9 (1.4) 1794 (457) 171 (21)
Shooting 20.8 (5.6) 6.1 (1.5) 2690 (773) 162 (16)
The broom 20.9 (4.5) 6.1 (0.7) 910 (552) 135 (16)
10 passes 22.5 (4.3) 6.6 (1.1) 2225 (1295) 152 (18)
The rocks 22.9 (8.7) 6.7 (1.8) 2460 (1377) 153 (20)
Balloon hunter 26.7 (5.8) 7.8 (1.1) 1874 (938) 151 (9)
Hop relay 26.7 (8.9) 7.8 (2.1) 5123 (2139) 157 (12)
Get in the car 27.7 (4.1) 8.1 (0.7) 2239 (444) 151 (15)
Countries 28.1 (10.1) 8.2 (0.5) 1514 (1260) 145 (47)
Rats and mice 28.5 (5.1) 8.3 (1.0) 2129 (1338) 142 (12)
Dodge 28.5 (10.5) 8.4 (1.4) 2444 (1314) 167 (22)
Football w/o ball 28.7 (11.3) 8.9 (2.0) 1898 (853) 142 (23)
Conveyors
HIPE group
31.3 (7.8) 9.2 (1.8) 3412 (569) 184 (10)
Steal the treasure 32.2 (7.7) 9.4 (0.9) 2640 (1107) 162 (10)
Stealing 
handball
32.4 (10.6) 9.4(0.5) 3001 (1336) 161 (48)
Stealing football 33.9 (10.2) 9.9 (0.7) 2877 (1398) 169 (52)
The 4 corners 37.3 (6.6) 10.8 (1.7) 3115 (505) 176 (14)
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1501   (645)
2695 (1586)




EE energy expenditure, HIPE high-intensity physical education, LIPE low-to-moderate intensity physical education
The data for each game is an average for 5 ± 1 subjects (with standard error). Games with VO2 up to 20 mL kg
–1 min–1. Games with VO2 between 20
and 30 mL kg–1 min–1. Games with VO2 above 30 mL kg
–1 min–1. A full description for the preparation and administration of these games can be found at
www.movidavida.org. Table taken from Cañete-García et al. [34]
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help to maintain compliance and to provide a detailed de-
scription of each playground games session. It is expected
that the gradual increase in total energy expenditure will
minimize fatigue, soreness, injuries, and attrition.
Data collection and outcome measures
Outcome measures will be assessed at baseline and at the
end of the 6-month intervention by personnel blinded to
the treatment allocation. Data will be recorded on stan-
dardized forms and entered into a secured Access database
that contains quality control checks (e.g., range checks and
notifications for missing data) (Fig. 2). Post-intervention
measurements will be scheduled within 7 days following
the last exercise session or last supervised program session
in the exercise and control groups, respectively.
The primary outcome measure is hepatic fat content,
which will be assessed with the controlled attenuation
parameter. The secondary outcomes of this study will test
the additional effects of exercise training on traditional car-
diometabolic risk factors [body composition, blood pres-
sure, glycohemoglobin (HbA1c), serum lipids, and insulin
resistance] and non-traditional cardiometabolic risk factors
(visceral adiposity, endothelial function, cytokines, adi-
pokines, aminotransferases, inflammatory biomarkers,
uric acid, ferritin, albumin, and cardiorespiratory and
muscular fitness). Also, we include neuronal function
biomarkers as measured by neurotrophin-3 (NT-3),
neurotrophin-4 (NT-4), and brain-derived neurotrophic
factor (BDNF) levels (second secondary objective). Finally,
attention capacity and psychological measurements will
be assessed to evaluate the additional effect of the exercise
intervention on the executive function, quality of life,
self-esteem, and well-being of overweight and obese par-
ticipants. Other covariables of interest include pubertal
development, physical activity levels, sedentary behavior,
dietary assessment, demographic characteristics, and side
effects (Table 2).
Primary outcome
The controlled attenuation parameter is the ultrasonic
attenuation coefficient of the ultrasonic signals used dur-
ing transient elastography examination and is expressed in
decibels per meter (dB/m; range from 112 to 242 dB/m),
acquired at a 3.5-MHz standard M probe (diameter
7 mm) with a FibroScan® 502 Touch Mode M. Before and
during the examination, the adolescent will lie on their
back with the right arm in maximum abduction, and
abdominal ultrasound will be used to identify a region of
the liver free of large vascular structures. The tip of the
FibroScan® transducer will then be placed on the skin
between the ribs over the right lobe of the liver, and the
liver stiffness will be recorded. The technical background
and reference values in the pediatric population (1 to
18 years) have been recently described in detail [36]. The
Fig. 2 Schedule of enrolment, intervention, and assessment in the
HEPAFIT study, according to the SPIRIT 2013 statement
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Table 2 Overview of the measurements and methodology at baseline and post-test in the HEPAFIT study
Measure Methodology
Primary outcome
Hepatic fat (%) Vibration-controlled transient elastograph
Secondary outcomes
Body mass (kg) Scale
Height (cm) Stadiometer
Waist circumference (cm) Non-elastic tape
Blood pressure Oscillometric monitor device
Heart rate Oscillometric monitor device
Lean mass (kg), total body fat (%), bone mineral density (g/cm2),
abdominal adiposity (g), truncal adiposity (g), limb adiposity (g)
Dual X-ray absorptiometry
Visceral adiposity (cm2) Bioelectrical impedance
High-density lipoprotein cholesterol (mg/dL), low-density lipoprotein
cholesterol (mg/dL), total cholesterol (mg/dL), total triglycerides
(mg/dL), serum glucose (mg/dL)
Enzymatic spectrophotometry
Serum insulin (mU/L) Electrochemiluminescence immunoassay
Glycohemoglobin (mg/dL) Electrochemiluminescence immunoassay
Alanine (U/L), aspartate (U/L), gamma-glutamyl transferase (U/L) Enzymatic assay
Uric acid, albumin (mg/dL), ferritin (mg/dL) Enzymatic assay
hs-C reactive protein, ENA-78, GCSF, GM-CSF, GRO, GRO-α, I-309,
IL-1α, IL-1β, IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IL-12 p40/p70,
IL-13, IL-15, IFN-γ, MCP-1, MCP-2, MCP-3, MCSF, MDC, MIG, MIP-1β,
MIP-1δ, RANTES, SCF, SDF-1, TARC, TGF-β1, TNF-α, TNF-β, EGF,
IGF-I, angiogenin, oncostatin M, thrombopoietin, VEGF-A, PDGF-BB,
leptin, BLC, Ckß8–1, eotaxin, eotaxin-2, eotaxin-3, FGF-4,
FGF-6, FGF-7, FGF-9, Flt-3 ligand, fractalkine, GCP-2, GDNF, HGF,
IGFBP-1, IGFBP-2, IGFBP-3, IGFBP-4, IL-16, IP-10, LIF, LIGHT, MCP-4,
MIF, MIP-3α, NAP-2, osteopontin, osteoprotegerin,
PARC, PLGF, TGF-β2, TGF-β3, TIMP-1, TIMP-2 (mean spot pixel densities)
Proteome Profiler human cytokine array
panel A kit
NT-3, NT-4, BDNF (pg/mL) Surface plasmon resonance biosensors
Flow-mediated dilation High-resolution ultrasound device
Carotid intima-media thickness High-resolution ultrasound device
Cardiorespiratory fitness 20-m shuttle run test
Cardiopulmonary exercise test
Muscular strength Handgrip strength
Standing long jump tests
Speed and agility 4 × 10 shuttle run test
Flexibility Sit-and-reach test
Attention capacity d2 attention test
Stroop task test
Physical activity enjoyment Physical activity enjoyment scale
Potential confounders
Physical activity and sedentary behavior Actigraph GT1M, dual-axis accelerometer
ActivPal
Dietary assessment 24-h diet record
Food frequency questionnaires
Pubertal development (Tanner stage) Questionnaire
Family medical history, demographic characteristics, socioeconomic status Questionnaire
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algorithm is included in the transient elastography soft-
ware and data are automatically calculated simultaneously
with the liver stiffness measurement.
Secondary outcome measures
Blood samples will be obtained from each subject early
in the morning by venipuncture from the antecubital
vein, following a 10-h overnight fast. Blood samples will
be drawn into a tube containing ~1.8 mg EDTA-K3 per
mL blood for plasma and a tube with a polymer gel for
serum determinations (Vacutainer, Becton Dickinson &
Company 2017). Samples will be handled according to
Clinical Laboratory Improvement Amendments, which
must be followed to achieve valid test results that can be
used for diagnoses [37]. Blood samples will be stored at
room temperature until centrifugation. Samples should
undergo centrifugation immediately. This will be carried
out at 1500g for 15 min at 4 °C and will give three layers
(from top to bottom): plasma, leukocytes (buffy coat),
and erythrocytes. The supernatant (plasma) and serum
will be carefully aspirated at room temperature and
aliquoted into cryovials. Finally, both samples will be
stored at −80 °C before the analysis of serum lipids,
adipokines, aminotransferases, inflammatory biomarkers,
uric acid, ferritin, albumin insulin, and neuronal function
biomarkers using surface plasmon resonance biosensors.
Serum lipids, including high-density lipoprotein choles-
terol (HDL-C), LDL-C, total cholesterol, and total trigly-
ceride, will be measured with an automatic biochemical
analyzer (Deyi Biomedical Technology Co., Ltd., Beijing,
China). Concentrations of serum insulin and HbA1c will
be analyzed with commercially available electrochemilu-
minescence immunoassay kits (Roche Diagnostics GmbH,
Mannheim, Germany). The homeostatic model assessment
of insulin resistance (HOMA-IR) and homeostatic model
assessment of pancreatic β-cell function (HOMA-β) indices
will be calculated with the following equation:
HOMA − IR ¼ fasting insulin ðFINS; Ins0Þ
 fasting blood glucose=22:5
and
HOMA − β ¼ 20 Ins0=ð fasting blood glucose − 3:5Þ
Alanine aminotransferase, aspartate aminotransferase,
and g-glutamyl transferase levels will be determined by
enzymatic assays (Beckman Coulter, Brea, CA, United
States). Uric acid, albumin, and ferritin will be measured
in an enzymatic spectrophotometer (Beckman Coulter,
Brea, CA, United States). All assays will be measured
in duplicate according to the manufacturers’ standard
procedures.
Non-traditional biomarkers will be evaluated for the pres-
ence and relative amounts of 80 different inflammatory
markers using a Proteome Profiler Human Cytokine
Array Panel A kit (R&D Systems, Minneapolis, MN)
(Additional file 1: Table S1). These include: hs-C reactive
protein, ENA-78, GCSF, GM-CSF, GRO, GRO-α, I-309,
IL-1α, IL-1β, IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10,
IL-12 p40/p70, IL-13, IL-15, IFN-γ, MCP-1, MCP-2,
MCP-3, MCSF, MDC, MIG, MIP-1β, MIP-1δ, RANTES,
SCF, SDF-1, TARC, TGF-β1, TNF-α, TNF-β, EGF, IGF-I,
angiogenin, oncostatin M, thrombopoietin, VEGF-A,
PDGF-BB, leptin, BDNF, BLC, Ckß8–1, eotaxin, eotaxin-2,
eotaxin-3, FGF-4, FGF-6, FGF-7, FGF-9, Flt-3 ligand, frac-
talkine, GCP-2, GDNF, HGF, IGFBP-1, IGFBP-2, IGFBP-3,
IGFBP-4, IL-16, IP-10, LIF, LIGHT, MCP-4, MIF, MIP-3α,
NAP-2, NT-3, NT-4, osteopontin, osteoprotegerin, PARC,
PLGF, TGF-β2, TGF-β3, TIMP-1, and TIMP-2.
This assay will be performed according to the instruc-
tions provided by the manufacturer. Briefly, 50–200 μL
of serum samples will be thoroughly suspended in
1.5 mL of array buffer 5, incubated at room temperature
for 15 min, and centrifuged for 5 min at 5000g. The
supernatant (1 mL each) will be added to a cocktail of
biotinylated antibodies and incubated at room temperature
for 1 h. The sample/antibody mixture will be subsequently
incubated at 4 °C for 19 h with a membrane embedded
with antibodies specific to each of the 80 different inflam-
matory markers analyzed. The pixel densities of each blot
(band), representing the amount of each inflammatory
marker present, will be determined using the ImageJ soft-
ware (National Institutes of Health, Bethesda, MD). These
non-traditional biomarkers will be measured in a random
sub-sample (n = 10, for each group).
Surface plasmon resonance allows real-time monitoring of
NT-3, NT-4, and BDNF (R&D Systems, Minnesota, USA).
In a typical experiment, the signal reflection, measured at a
fixed angular position, is evaluated as a function of time.
The real-time quantification will use a specific anti-protein
antibody/protein. All experiments will be carried out at
25 °C using a Biacore 2000 instrument with a CM5 chip
(Biacore, Uppsala, Sweden). HBS-EB buffer (10 mM
4-(2 hydroxyethyl) piperazine-1-ethanesulfonic acid
[HEPES], 150 mM NaCl, 3 mM ethylene diamine tetra-
acetic acid [EDTA], 0.005% Tween 20, pH 7.4) will be
used as a continuous running buffer at a 5–60 μg/mL
flow rate. The antibodies (ligand) anti-NT-3, anti-NT-4,
and anti-BDNF will be immobilized onto the CM5 sen-
sor surface at a concentration range of 10–50 μg/mL.
Before immobilization of the antibodies, the sensor sur-
face will be activated via an amino-coupling chemistry
kit [1-ethyl-3-(3′-dimethylaminopropyl) carbodiimide,
N-hydroxysuccinimide (GE Healthcare, Uppsala, Sweden)].
For the immobilization steps, the basic principles of assays
using surface plasmon resonance will be applied, such as
preconcentration and a binding assay with the analyte. Each
antibody solution will be injected individually to couple with
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the activated surface until the appropriate immobilization
level is achieved. Activated carboxyl group excess will be
blocked by 1 M ethanolamine hydrochloride (pH 8.5). A
reference or control flow cell with 50 μg/mL bovine serum
albumin (Sigma-Aldrich, Saint Louis, MO) at pH 5.0,
but no immobilizing solution, will be used to subtract
the instrument systematic noise and drift (background
response). After each injection of a binding assay with
the analyte and standard samples, an optimal regeneration
solution will be injected in agreement with previous studies
[38, 39]. The percentage of surface regeneration will be esti-
mated using [1 − (Rreg/Ro) × 100]. If the percentage regen-
eration achieved is below 10%, other regeneration solutions
should be injected until the percentage regeneration is
higher than 50%. Standard curves will be constructed by
dilution of each standard recombinant protein NT-3, NT-4,
and BDNF. A range of 20–5000 ng/mL will be used to
obtain the curve. Each sample of protein will be injected in
triplicate.
Diluted plasma samples will be quantified and the
binding response will be calculated by subtracting the
response measured in the control flow cell from the re-
sponse in the sample flow cell. This value is applied to the
simple 1 :1 L binding model (A + B or AB). The Langmuir
model is the most commonly used model for calculating
binding affinity. The report points will be taken 10 s be-
fore and 100 s after taking a measurement and the differ-
ence between these two report points will be taken as the
end-point measurement.
Endothelial function Endothelial function may poten-
tially represent a quantitative method to assess the pres-
ence and extent of childhood cardiometabolic risk before
the development of overt disease [40]. Flow-mediated dila-
tion will be measured with the technique introduced by
Ramírez-Vélez [41] in the Colombian population, using
the guidelines reported by Corretti et al. [42]. The
diameter of the brachial artery will be assessed using a
high-resolution ultrasound device (Mindray M-9®,
Shenzhen, China), equipped with a 7.5–10 MHz linear
array transducer and an integrated electrocardiography
package. B-mode images were obtained at a reprodu-
cible point in the distal third of the upper arm.
Endothelium-dependent vasodilation was assessed by
measuring flow-mediated dilation after 5 min of fore-
arm ischemia [43]. All measurements will be taken at
the end of diastole as observed by electrocardiogram
(ECG). Briefly, a 1-min baseline measurement will be
taken and then a pneumatic rapid cuff inflator (Hokanson,
Bellevue, WA), placed around the forearm distal to the
humeral epicondyle, will be inflated to 220 mmHg for
5 min. Recording of the image will be ceased on inflation
of the cuff and recommenced 30 s before deflation. Peak
dilation during each study will be defined as the greatest
percentage change from the resting baseline brachial
artery diameter. The intra-session coefficients of varia-
tions will be ≤1% for the baseline diameter. Reliability,
estimated by intra-class correlation coefficients based
on four baseline measurements (n = 8 subjects), showed
an intra-class correlation coefficient of 0.91 for the
baseline diameter and 0.83 for flow-mediated dilation
(unpublished observations). Images will be recorded on
a DVD player for subsequent measurements by one ob-
server blinded to the study.
Carotid intima-media thickness The carotid
intima-media thickness (cIMT) will be assessed using
semi-automated B- and M-mode ultrasound, (Mindray
M-9®, Shenzhen, China) with a high-frequency linear-array
probe (5–13 MHz) [44]. In brief, the left and right common
carotid arteries will be imaged at a standardized magnifica-
tion (2 × 2 cm). A participant’s head will be turned 45° away
from the site being scanned. Optimal images will be cap-
tured at the end of diastole, incident with the R-wave of the
ECG, for later analysis. Our inter-observer intra-class coef-
ficient for cIMT measurements is 0.99 (coefficient of vari-
ation 0.99%) and the intra-observer intra-class coefficient
for cIMT measurements is 0.98 (coefficient of variation
1.9%) (unpublished observations).
Anthropometric measures Variables will be collected at
the same time in the morning, between 7:00 and 10:00 a.m.,
following an overnight fast. The body weight of the subjects
will be measured when the subjects are in their underwear
and not wearing shoes, using electronic scales (Tanita®
BC544, Tokyo, Japan). Height (using a stadiometer, Seca®
213, Hamburg, Germany), waist circumference, and hip
circumference will be measured in centimeters using a tape
measure (Ohaus® 8004-MA, Parsippany, NJ, USA). The
waist circumference is measured as the smallest circumfer-
ence around the torso between the end of the xiphisternum
and the top of the iliac crests. The hips are measured at the
greatest circumference between the iliac crests and the
upper femur. Body mass index (BMI) will be calculated as
the body weight in kilograms divided by the square of the
height in meters. BMI will be classified as underweight,
normal weight, overweight, or obese using the World
Health Organization criteria [45]. The anthropometric
measurements will be conducted by a nutritionist in ac-
cordance with International Society for the Advance-
ment of Kinanthropometry guidelines [46]. The mean
of three consecutive measurements will be recorded.
Body composition We will also measure fat mass, lean
body mass, and subcutaneous abdominal fat by conduct-
ing a dual-energy X-ray absorptiometry (DEXA) scan
(HOLOGIC, QDR 4500 W). Visceral fat volume will be
measured by bioelectrical impedance. An experienced
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DEXA technologist blinded to the study randomization
will perform the DEXA imaging studies. The mean pre-
cision of our machine is 1.1% for soft tissue (unpub-
lished observations).
Physical fitness Physical fitness includes cardiorespira-
tory fitness, muscular strength, speed and agility, and
flexibility. Moreover, physical fitness has been reported
as a powerful marker of health in childhood, and its in-
clusion in the definition of metabolic syndrome has been
proposed [47]. Cardiorespiratory fitness will be mea-
sured using the 20-m shuttle run test as previously de-
scribed by Léger et al. [48]. The cardiorespiratory profile
will be derived by computing standardized values of the
number of completed laps performed by each participant
by age and sex. Upper-body isometric strength (handgrip
strength test) will be assessed using a handgrip dyna-
mometer, (T.K.K. 5001, Grip-A, Takei, Japan), adjusted
by sex and hand size for each adolescent [49]. The par-
ticipants will be instructed to stand with their arms
completely extended, squeezing the handgrip gradually
and continuously up to the maximum of their strength,
for at least 2 s, performing the test twice, alternating
hands. The best score for each hand will be recorded in
kilograms. The handgrip score (kg) will be calculated as
the average of the left and right grip strength and then
expressed per kilogram of body weight [50]. Lower-body
explosive strength (standing long jump test) will be
tested in an indoor gymnasium with a wooden floor.
The adolescents will be instructed to push off vigorously
from the starting line to jump as far forward as possible
while landing on both feet and staying upright [51]. The
test will be done twice, and the best attempt will be re-
corded. The standing-jump score will be determined by
the distance between the last heel mark and the take-off
line. The results of the handgrip strength and standing
long jump tests will be transformed into standardized
values (z scores) by age and sex. The z scores of the two
tests will be added together to yield the muscular fitness
score. Speed and agility (movement speed, coordination,
and agility assessment) will be measured using the 4 × 10
shuttle-run test. The time that it takes to complete the
test will be recorded to the nearest tenth of a second
[52]. Flexibility will be measured according to the stand-
ard sit-and-reach test for range of movement (in cm).
Resting blood pressure and heart rate An automated
device will measure resting HR and blood pressure. Par-
ticipants will be instructed to rest for 10 min prior to
the measurement. HR and blood pressure will be mea-
sured twice from the dominant arm while the subject is
in a supine position. This will occur at the initial screen-
ing visit and 30 min after training.
Attention capacity The d2 test of attention is a paper
and pencil test that consists of 14 different lines of 47
randomly mixed letters (“p” or “d”). Briefly, for each line,
the adolescents will be given 20 s to identify and mark
the letter “d” when it is presented with two dashes
placed above and/or below it (i.e., relevant elements).
The remaining combinations are considered irrelevant
elements. After 20 s, there is an acoustic signal, which
prompts the participants to progress to the next line.
Their attention capacity will be calculated as the number
of correct relevant elements minus the number of irrele-
vant elements marked. The score will be transformed
into age-specific percentiles. Thus, a higher attentional
ability is indicated by a higher score [53].
Stroop task test We will use the New Stroop Test II
(Spanish version). This test measures selective attention,
cognitive flexibility, and processing speed. It is used to
evaluate executive function [54]. The test consists of two
control tasks: a Stroop task and a reverse Stroop task.
The number of correct answers, reverse-Stroop interfer-
ence rate, and Stroop interference rate will be calculated.
Physical activity enjoyment scale Before, during, and
immediately upon completion of each protocol, partici-
pants will also rate their perceived enjoyment according
to the physical activity enjoyment scale, which has been
validated by Kendzierski and DeCarlo [55]. Each item is
rated on a seven-point bipolar scale with four represent-
ing a neutral point in terms of how much the respond-
ent enjoyed the exercise.
Physical activity and sedentary behavior The Acti-
graph GT3x dual-axis accelerometer (Actigraph, Pensacola,
FL, USA) and ActivPAL monitor (PAL Technologies Ltd.,
Glasgow, UK) will be used. The Actigraph GT3x measures
vertical accelerations from 0.05g to 2g, sampled at 30 Hz, at
5-s epoch intervals. The ActivPAL summarizes data in 15-s
epoch intervals over 24 h at a sampling frequency of 10 Hz.
Before the beginning of each MOVI-2 program session, the
accelerometer will be positioned at the waist in line with
the right axilla, at the level of the iliac crest of the right hip
and secured by an elastic belt round the hip. The Actigraph
GT3x has been validated for estimating energy expenditure
during physical activity in a youth population [56]. Data
from the accelerometer will be used to calculate the average
counts/min for each game. Accelerometers will also be
worn continuously for seven consecutive days to record
physical activity intensity levels and patterns, as well as
sleeping habits. Participants will also complete a diary log.
Data stored in the device will be analyzed using the
ACTi-life 6.01 software.
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Dietary assessment To determine the average habitual
energy and macronutrient intake, a detailed 24-h diet
record will be obtained from each adolescent for one
weekday and one weekend day during the 1-week baseline
period. Food intake analysis software (FAO/INFOODS,
Report of the Technical Workshop on Standards for Food
Composition Data Interchange, Rome 2004) and national
food composition tables (for specific foods) will be used to
analyze the total energy and macronutrient intake of each
subject’s 24-h diet. The dietary assessment will be con-
ducted by a registered nutritionist.
Sociodemographic information Baseline sociodemo-
graphic values (sex, highest educational level attained by
mother/father, composition of household, others), which
could act as covariates or confounders for the tested
treatment modality, will also be collected. The surveys
will include questions on age, education, occupation, in-
come, health history, and alcohol consumption, among
others.
Side effects and monitoring The study will be con-
ducted according to good clinical practice and standard
operating procedures. It will be monitored by the Human
Rights Committee at the Universidad del Rosario Coordin-
ating Centre, a committee composed of experts in physical
exercise and sports medicine, plus physical therapists,
physical educators, and clinical epidemiologists. Interim
monitoring reports will be submitted to the experts, fo-
cusing on patient intake, adherence to the protocol,
baseline comparability of treatment groups, complete-
ness of data retrieval, and adverse events. All adverse
events will also be reported to the Universidad del Rosario
Ethics Committee. To standardize the study procedures,
an operations manual has been written, and comprehen-
sive training sessions will be held prior to initiation of the
trial. An independent researcher will be in charge of audit-
ing all assessment staff to record all of these events for the
participants over the study period.
Power calculation and sample size
Change in liver fat is the primary outcome of this study.
For liver fat measured by a FibroScan 502®, a sample size
of 100 will have 80% power to detect a difference in hep-
atic fat of 5.0% assuming a standard deviation of 4.1%
and an α of 0.025 for a two-sided significance level. As-
suming a maximum a loss of follow-up of 10%, we de-
cided to recruit a total of 100 subjects, 25 participants
for each group. We assume that the dropout rate will be
similar to that in our previous studies performed in a
young overweight population with a similar age range
and a similar intervention program [18, 23–25, 57–59].
The sample size will allow for multivariate analyses with
up to three predictors, assuming moderate size effects.
Blinding and randomization
Each participant will have a 0.25 probability of being
assigned to any study group. This assignment will be
made through previously constructed balanced blocks.
These blocks permit an equi-probabilistic assignment
and ensure that each group has the same number of par-
ticipants. This assignment mechanism will continue
until all 100 participants have been assigned to their in-
terventions. The study’s health personnel will act inde-
pendently of the personnel in the school from where the
participants are selected. Therefore, they do not carry
out any school activities and their tasks are limited to
collecting data for this study. The assignment codes will
be maintained in a confidential file in the research cen-
ter of the coordinating group and will be opened when
the study analysis is finished. At the beginning and end
of their participation in the study, the primary and sec-
ondary outcomes will be determined for each of the
patients.
Given that physical exercise is an intervention that
cannot be masked from the participants or researchers,
professionals who are unaware of each subject’s group
assignment will perform the measurement and analysis of
the resulting variables. To ensure masking, randomization
will be applied through balanced blocks and an alphabetical
code will be assigned to each study group. This code will be
in the custody of the administrative coordinator of the re-
search group and will not be revealed to the professionals
in charge of processing the data until the analysis with
coded interventions has terminated.
Adherence and compliance
The CEMA research center is responsible for preparing
the reports for the safety committee to audit the study’s
progress. These reports will include the following infor-
mation: (a) recruitment and follow-up per person per
month and comparison with the pre-established goals,
(b) adherence of participants (biochemical markers and
data on the degree of compliance and a comparison with
the objectives foreseen for the exercise groups, (c)
quality control (preferences for certain digits, variability,
and values out of range), and (d) intermediate and final,
primary, and secondary variables for each group and
comparisons among groups with respect to the primary
variables and other secondary variables. For the
interventions with additional exercise, 75% adherence is
expected of the 72 planned sessions, along with at least
70% training compliance.
Data quality
To evaluate the veracity of the data from the question-
naires and from the database, an external personnel team
assigned to each group will revise the instruments and
questionnaires for a random number of participants. The
González-Ruíz et al. Trials  (2018) 19:330 Page 12 of 16
proposal is to review the data from approximately 25% of
the participants in each group, and CEMA members will
confirm and certify the validity of the data. The CEMA re-
searchers will create a system to access the study data
through a private website (http://www.urosario.edu.co/
cema/inicio/), from where authorized researchers can
download all the forms, databases, and articles published.
For security and privacy, a valid ID and password are ne-
cessary to access the data and the forms. This web-based
system is used to send data to the data manager. As a
quality control measure, the principal study data will be
reviewed for features such as a preference for certain fig-
ures and data variability. All the forms will be entered in
duplicate and they will be checked for inconsistencies and
missing data. To minimize potential error, a Manual of
Operations has been drafted. Until the end of the trial,
personnel from the groups will have access to all the infor-
mation from the trial, except for the statisticians and the
safety committee.
Statistical analysis
The final data will be analyzed using IBM SPSS 22.0
(SPSS, Inc., Chicago, IL, USA) and SAS software (SAS
Institute Inc., Cary, NC, USA). An exploratory analysis
will be performed to determine the frequency, range,
variability, and distribution type for each variable to estab-
lish the most appropriate statistical test when comparisons
are necessary. These analyses will assess the primary out-
come (hepatic fat) and will be undertaken using the
intention-to-treat principle. The intention-to-treat analysis
for this study will include all participants, including those
who are not fully compliant and those with missing out-
come data.
Because this is an experimental design with the primary
and secondary outcomes measured twice, the first at base-
line (t0 = 0 months) and the second after the interventions
(t1 = 6 months), for four study groups, a comparative ana-
lysis between the measurements will determine the differ-
ences. A linear mixed model with repeated observations
will be used for these comparisons, when appropriate, for
each dependent variable. Subsequently, a multivariate
analysis will be carried out, and the autocorrelation
between repeated measures will be taken into account.
We will use longitudinal analysis methods, such as a
generalized estimating equation approach, to control
the differences among measurements at baseline and
to incorporate incomplete observations into this analysis.
Pearson correlations will be calculated between the max-
imal values of the primary and secondary outcomes. Fi-
nally, we will investigate whether there is an interaction
between the two interventions for the primary outcome
after 30–40 min of supervised HIPE and LIPE or com-
bined training (HIPE + LIPE). For these analyses, we will
include appropriate interaction terms in the models [60].
We plan to report regression coefficients for the inter-
action terms and their 95% confidence intervals.
Discussion
The relevance of this project is that the results obtained
from the objectives proposed will contribute to our un-
derstanding of the links between excess weight and alter-
ations in hepatic and adipose metabolism. Moreover, we
may be able to identify biomarkers for metabolic abnor-
malities associated with central obesity that are involved
in the induction of oxidative dysfunction processes via
lipotoxicity, which is common in physical inactivity and
obesity, such as pathologies related to the cardiometabolic
system. The study of biomarker profiles in adolescents with
metabolic syndrome and obesity compared to a normal
weight population could assist in the early diagnosis of car-
diovascular diseases. Future studies are warranted to verify
the relevance of the biomarkers associated with obesity and
elucidate the underlying biochemical processes.
Currently, the management of overweight conditions
and public information on the topic have focused on
treatments such as caloric restriction, physical exercise,
and different drugs. There have been promising results,
due to the distinct metabolic adaptations that can prove
beneficial for individuals with excess weight. Thus, our
research hypothesis is that some physical exercise programs
will generate a higher reduction of fat in liver than other
interventions. In addition, there may be improvements in
the hepatic metabolism and cardiovascular health of over-
weight/obese adolescents from the district of Bogotá.
At a clinical level, interventions to prevent excess weight
and sedentary habits are very costly and the results in the
pediatric setting are discouraging and not very cost-effective
[60–62]. Hence, our research seeks to evaluate the impact of
the interventions, and whether they are easy to implement,
safe, economic, and free of secondary effects. The research
focuses on assessing hepatic metabolic activity (fat content,
as a primary outcome) and bodily composition, blood
pressure, insulin sensitivity, lipid and carbohydrate me-
tabolism, and physical condition (secondary outcomes),
which are highly relevant.
Because adolescence is a critical period in the selection
of and preferences for particular forms of conduct and
behavior, it is necessary to promote strategies that help
in strengthening healthy habits during this time of life.
We postulate that interventions such as supervised physical
exercise aimed at preventing metabolic dysfunction, which
is characterized by excess weight and sedentary habits,
could diminish the incidence or progression of non-chronic
disease. The aforementioned hypothesis is based on solid
evidence, which shows that engaging regularly in vigorous
physical exercise for at least 12 weeks improves physical
condition [63, 64], body composition [65], and most cardio-
vascular risk factors [19]. However, even though they are
González-Ruíz et al. Trials  (2018) 19:330 Page 13 of 16
safe interventions [18, 19], the effect of different exercise
intensities, and in particular, high-intensity work, on liver
metabolism is unknown [66].
Dissemination
We will disseminate the results of our study via presen-
tations at international conferences and articles in
peer-reviewed journals. The study will be implemented
and reported in accordance with the SPIRIT guidelines
(Standard Protocol Items: Recommendations for Inter-
ventional Trials) [67] (Additional file 2).
Future directions
In the short term, this project offers the opportunity to
obtain detailed measurements of body composition,
cardiometabolic health, and hepatic function in over-
weight children and adolescents. It will yield informa-
tion on the effects of physical exercise on them. In the
long term, we expect that the results obtained will
deepen our knowledge of the effects of supervised
physical exercise in the school environment on some of
the most frequent metabolic disorders, as well as valid-
ate strategies that promote actions aimed at mitigating
the risk of the occurrence of these disorders and reducing
morbidity. Both of the latter are seen as priority problems
by the Ministry of Health and Social Protection. Our work
lies within the normative framework for generating pre-
ventive alternatives and effective therapeutics described in
Colombia’s Integral Health Information System and the
Public Health Surveillance System.
Trial status
The recruitment of adolescents started in January 2018
and will continue through the end of December 2018.
Additional files
Additional file 1: Non-traditional biomarkers. (DOCX 19 kb)
Additional file 2: SPIRIT 2013 Checklist: Recommended items to address
in a clinical trial protocol and related documents. (DOC 125 kb)
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